Literature DB >> 7989915

A longitudinal study of substance use and community violence in schizophrenia.

B J Cuffel1, M Shumway, T L Chouljian, T MacDonald.   

Abstract

The authors report the findings of a longitudinal study testing the hypothesis that substance use leads to subsequent violence in the community. Subjects were 103 patients with a Structured Clinical Interview for DSM-III-R diagnosis of schizophrenia or schizoaffective disorder who were seen in an outpatient clinic for the treatment of schizophrenia. Data on substance use and violent behavior were collected by review of medical records. Results indicated that use of drugs and alcohol was associated with increased odds of concurrent and future violent behavior when compared with persons with schizophrenia and no substance use. Odds of violence were particularly elevated for individuals having a pattern of polysubstance use involving illicit substances.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989915     DOI: 10.1097/00005053-199412000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  19 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

2.  A call for standardized definition of dual diagnosis.

Authors:  Kathyrn Hryb; Rob Kirkhart; Rebecca Talbert
Journal:  Psychiatry (Edgmont)       Date:  2007-09

Review 3.  Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Authors:  David A Smelson; Lisa Dixon; Thomas Craig; Stephen Remolina; Steven L Batki; Noosha Niv; Richard Owen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.

Authors:  R E Clark; G B Teague; S K Ricketts; P W Bush; H Xie; T G McGuire; R E Drake; G J McHugo; A M Keller; M Zubkoff
Journal:  Health Serv Res       Date:  1998-12       Impact factor: 3.402

Review 5.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

Review 6.  Importance of clinical diagnoses for comorbidity studies in substance use disorders.

Authors:  Marta Torrens; Rocío Martin-Santos; Sharon Samet
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

7.  Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.

Authors:  Mary F Brunette; Robert E Drake; Haiyi Xie; Gregory J McHugo; Alan I Green
Journal:  Schizophr Bull       Date:  2006-06-16       Impact factor: 9.306

8.  The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Authors:  Michael T Compton; Paul S Weiss; Joyce C West; Nadine J Kaslow
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-25       Impact factor: 4.328

9.  Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.

Authors:  Clara M Bradizza; Stephen A Maisto; Paula C Vincent; Paul R Stasiewicz; Gerard J Connors; Nicole D Mercer
Journal:  J Consult Clin Psychol       Date:  2009-12

10.  Individual and contextual-level factors associated with continuity of care for adults with schizophrenia.

Authors:  Cynthia A Fontanella; Joseph Guada; Gary Phillips; Lorin Ranbom; John C Fortney
Journal:  Adm Policy Ment Health       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.